A personalised mRNA vaccine for melanoma, the deadliest form of skin cancer, is expected to be approved for use in the US, Europe and Europe and the UK next year. The vaccine is expected to be approved for use in the US, Europe and the UK next year.
register or log in to get more services such as weather report, extended news articles and web search